JAMA Oncology/X
Jun 16, 2026, 15:26
JAMA Oncology: Avelumab Plus Methotrexate in Gestational Trophoblastic Tumors
JAMA Oncology shared a post on X about a paper by Benoit You et al. published in JAMA Oncology:
“Avelumab combined with methotrexate resulted in >95% durable remission and preserved fertility in low-risk gestational trophoblastic tumors, with a manageable safety profile.”
Title: Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors
Authors: Benoit You, Jean-Pierre Lotz, Pierre Descargues
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 3, 2026, 16:29Arora Suhani Gagan: Adolescent Healthcare Requires Sensitivity and Professional Responsibility
-
Nov 3, 2026, 16:09Shant Apelian: Narrative Review on Fertility Preservation for Patients Undergoing in Pelvic Malignancy Treatment
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026